May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Elvina Almuradova: Targeting c-MET overexpression is reshaping EGFR-mutant NSCLC treatment
Jan 25, 2025, 12:41

Elvina Almuradova: Targeting c-MET overexpression is reshaping EGFR-mutant NSCLC treatment

Elvina AlmuradovaOncology Unit Lead at Can Hospitals Turkey, shared a post on X:

“Breaking News from Annals of Oncology! Targeting c-MET overexpression is reshaping EGFR-mutant NSCLC treatment!

  • Teliso-V + Osimertinib combo:
  • 50% ORR and 7.4 months PFS
  • ADCs are the future for osimertinib-resistant NSCLC!”

Elvina Almuradova: Targeting c-MET overexpression is reshaping EGFR-mutant NSCLC treatment